Cargando…

Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort

SIMPLE SUMMARY: We performed a cohort study based on the Swedish Apolipoprotein-Related Mortality Risk (AMORIS) Cohort, including 561,388 individuals and with a follow-up of >30 years, to assess the associations of nine blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolism with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xue, Huang, Yi, Sadeghi, Fetemeh, Feychting, Maria, Hammar, Niklas, Fang, Fang, Zhang, Zhe, Liu, Qianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856513/
https://www.ncbi.nlm.nih.gov/pubmed/36672472
http://dx.doi.org/10.3390/cancers15020520
_version_ 1784873649160847360
author Xiao, Xue
Huang, Yi
Sadeghi, Fetemeh
Feychting, Maria
Hammar, Niklas
Fang, Fang
Zhang, Zhe
Liu, Qianwei
author_facet Xiao, Xue
Huang, Yi
Sadeghi, Fetemeh
Feychting, Maria
Hammar, Niklas
Fang, Fang
Zhang, Zhe
Liu, Qianwei
author_sort Xiao, Xue
collection PubMed
description SIMPLE SUMMARY: We performed a cohort study based on the Swedish Apolipoprotein-Related Mortality Risk (AMORIS) Cohort, including 561,388 individuals and with a follow-up of >30 years, to assess the associations of nine blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolism with the subsequent risk of thyroid cancer. In brief, we found that increased blood levels of total cholesterol and HDL-C were associated with a lower risk of thyroid cancer and, as a group, patients with thyroid cancer had constantly lower levels of total cholesterol and HDL-C during the decades before diagnosis, compared to controls. We also found that, during the 10 years before diagnosis, patients with thyroid cancer demonstrated declining levels of lipid and apolipoprotein biomarkers, whereas controls demonstrated stable or increasing levels likely because of aging. ABSTRACT: Background: Previous studies have examined the link between blood metabolic biomarkers and risk of thyroid cancer, with inconclusive results. We performed a cohort study based on the Swedish Apolipoprotein-Related Mortality Risk (AMORIS) Cohort, including 561,388 individuals undergoing health examinations during 1985–1996 with a follow-up of >30 years. Methods: Newly diagnosed cases of thyroid cancer were identified from the Swedish Cancer Register. We assessed the associations of nine blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolism measured at the time of health examinations with the subsequent risk of thyroid cancer and demonstrated the temporal trend of these biomarkers during the 30 years before diagnosis of thyroid cancer. Results: After multivariable adjustment, there was a lower risk of thyroid cancer, per standard deviation increase in total cholesterol (TC; HR 0.91; 95%CI 0.82–0.99) and HDL-C (HR 0.86; 95%CI 0.75–0.99). During the 20 to 30 years before diagnosis, patients with thyroid cancer, as a group, demonstrated constantly lower levels of TC and HDL-C, compared to controls. Further, patients with thyroid cancer demonstrated declining levels of these biomarkers during the ten years before diagnosis, whereas controls demonstrated stable or increasing levels. Conclusions: Taken together, we found blood levels of TC and HDL-C to be associated with the risk of thyroid cancer and that there was a declining level of metabolic biomarkers during the 10 years before diagnosis of thyroid cancer.
format Online
Article
Text
id pubmed-9856513
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98565132023-01-21 Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort Xiao, Xue Huang, Yi Sadeghi, Fetemeh Feychting, Maria Hammar, Niklas Fang, Fang Zhang, Zhe Liu, Qianwei Cancers (Basel) Article SIMPLE SUMMARY: We performed a cohort study based on the Swedish Apolipoprotein-Related Mortality Risk (AMORIS) Cohort, including 561,388 individuals and with a follow-up of >30 years, to assess the associations of nine blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolism with the subsequent risk of thyroid cancer. In brief, we found that increased blood levels of total cholesterol and HDL-C were associated with a lower risk of thyroid cancer and, as a group, patients with thyroid cancer had constantly lower levels of total cholesterol and HDL-C during the decades before diagnosis, compared to controls. We also found that, during the 10 years before diagnosis, patients with thyroid cancer demonstrated declining levels of lipid and apolipoprotein biomarkers, whereas controls demonstrated stable or increasing levels likely because of aging. ABSTRACT: Background: Previous studies have examined the link between blood metabolic biomarkers and risk of thyroid cancer, with inconclusive results. We performed a cohort study based on the Swedish Apolipoprotein-Related Mortality Risk (AMORIS) Cohort, including 561,388 individuals undergoing health examinations during 1985–1996 with a follow-up of >30 years. Methods: Newly diagnosed cases of thyroid cancer were identified from the Swedish Cancer Register. We assessed the associations of nine blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolism measured at the time of health examinations with the subsequent risk of thyroid cancer and demonstrated the temporal trend of these biomarkers during the 30 years before diagnosis of thyroid cancer. Results: After multivariable adjustment, there was a lower risk of thyroid cancer, per standard deviation increase in total cholesterol (TC; HR 0.91; 95%CI 0.82–0.99) and HDL-C (HR 0.86; 95%CI 0.75–0.99). During the 20 to 30 years before diagnosis, patients with thyroid cancer, as a group, demonstrated constantly lower levels of TC and HDL-C, compared to controls. Further, patients with thyroid cancer demonstrated declining levels of these biomarkers during the ten years before diagnosis, whereas controls demonstrated stable or increasing levels. Conclusions: Taken together, we found blood levels of TC and HDL-C to be associated with the risk of thyroid cancer and that there was a declining level of metabolic biomarkers during the 10 years before diagnosis of thyroid cancer. MDPI 2023-01-14 /pmc/articles/PMC9856513/ /pubmed/36672472 http://dx.doi.org/10.3390/cancers15020520 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xiao, Xue
Huang, Yi
Sadeghi, Fetemeh
Feychting, Maria
Hammar, Niklas
Fang, Fang
Zhang, Zhe
Liu, Qianwei
Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
title Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
title_full Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
title_fullStr Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
title_full_unstemmed Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
title_short Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
title_sort carbohydrate, lipid, and apolipoprotein biomarkers in blood and risk of thyroid cancer: findings from the amoris cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856513/
https://www.ncbi.nlm.nih.gov/pubmed/36672472
http://dx.doi.org/10.3390/cancers15020520
work_keys_str_mv AT xiaoxue carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT huangyi carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT sadeghifetemeh carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT feychtingmaria carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT hammarniklas carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT fangfang carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT zhangzhe carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort
AT liuqianwei carbohydratelipidandapolipoproteinbiomarkersinbloodandriskofthyroidcancerfindingsfromtheamoriscohort